Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @adrenomed
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @adrenomed
-
Adrenomed AG proslijedio/la je Tweet
Today is
#WorldCancerDay
- many people still aren't aware of the relationship between #cancer and#sepsis - sepsis rates are 4 times higher in cancer patients, and cancer patients have a 55% higher chance of dying from sepsis than non-cancer patients.#StopSepsis |#SaveLivespic.twitter.com/ab1m1TLvoJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Sepsis is killing more people than cancer. Learn more about Adrenomed’s lead product candidate: a first-in-class antibody counteracting vascular leakage and shock to rescue#vascularintegrity in sepsis. http://www.adrenomed.com https://twitter.com/bbchealth/status/1217856840387698688 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
@Adrenomed wishes you a great start of #2020. We will kick off the new year by travelling to#SanFrancisco for networking and 1o1s at#JPM. Our CEO, CBO and our CSO will represent the Company. We look forward to a successful experience in#California http://www.adrenomed.com pic.twitter.com/EVBNMktkvi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adrenomed AG proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Today, leading experts will meet in Berlin during the symposium “Mortality in Sepsis” co-hosted by
@Adrenomed. The event will cover many topics, including how applying novel therapies and#diagnostic tools can positively impact the journey of a patient w/#sepsis or#septicshock.pic.twitter.com/b9SMjzXomI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
@Adrenomed develops a new strategy against#sepsis: tackle the disease heterogeneity through intervening downstream in the pathological process by targeting#vascularintegrity. Read more about the science behind it and the company’s mission in@BioCentury https://bit.ly/354eBAj pic.twitter.com/DRSogoUJfj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
„Umsteuern bei
#Sepsis“ in der neuen@transkriptde Ausgabe: Von gesundheitspolitischen Maßnahmen über Diagnostika bis hin zu innovativen personalisierten Therapieansätzen wie dem Antikörper#Adrecizumab https://bit.ly/2CEQUSU pic.twitter.com/ClqnIwzybh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today, our CBO, Dr. Hein, will give a
#company presentation at#BIOEurope, 11:15 AM, Level 1/Hall B1/Room 6
. Join and discover how #Adrenomed tackles#septicshock by restoring#vascularintegrity with its first-in-class#Adrecizumab https://bit.ly/2BuxeAS pic.twitter.com/cSXeP8Dw2t
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#BIOEurope opens its doors to countless networking opportunities for global life science partners. Are you ready? Dr. Schneider-Mergener, CEO, Dr. Hein, CBO, are representing@adrenomed at the conference. Join the company presentation tomorrow

https://bit.ly/2ozSdPH pic.twitter.com/J9nBOKHAZU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In less than a week,
@adrenomed will be heading off to#Hamburg to attend#BIOEurope, 11-13.11.! Join the company presentation to learn about our program to rescue#vascularintegrity in#sepsis! See you there! https://bit.ly/2ozSdPH@EBDgrouppic.twitter.com/lsywryxVDW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adrenomed AG proslijedio/la je Tweet
Sepsis is a really tough field, but
@adrenomed is trying a new approach; it's not about the cause, they say, but about the progression to septic shock. Via@BioCenturyhttps://www.biocentury.com/bc-innovations/product-development/2019-10-31/adrenomed-braving-difficult-field-sepsis-targeting- …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are getting ready for
#BIOEurope, EU's largest life science partnering conference,#Hamburg 11-13.11! Use#partneringONE@EBDgroup to set up a meeting with us and discover the potential of our lead product, the first-in-class#Adrecizumab



https://bit.ly/2ozSdPH pic.twitter.com/zU2mg0O1om
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adrenomed AG proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Adrenomed AG proslijedio/la je Tweet
BIO-Europe® 2019:
#LifeSciences companies follow the footsteps of#Hamburg’s ancient merchants as they gather to celebrate innovation and partnership#BIOEuropehttps://cutt.ly/sehsWZWHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adrenomed AG proslijedio/la je Tweet
#BIOEurope did you know: The many waterways of Hamburg are spanned by around 2,500 bridges—more than the bridges in Venice, Amsterdam & London combined? Come see beautiful Hamburg for yourself. Register now ->https://bit.ly/2N4yHVIHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adrenomed AG proslijedio/la je Tweet
Partnering is now open for
#BIOEurope 2019! Register now and be ready to request meetings with 4,500+ potential partners
>> http://spr.ly/60141E3t6 pic.twitter.com/YTJpmvhvSX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
It was a splendid experience
@ESICM#lives2019. We thank Prof. Peter Pickkers@Radboud_Uni for his talk “#Adrenomedullin in#sepsis, effect of the non-inhibitory antibody#Adrecizumab” and all participants and organizers for this amazing event.pic.twitter.com/hsYQg3CuMr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today, Dr. Peter Pickkers
@Radboud_Uni will give a talk “#Adrenomedullin in#sepsis, effect of the non-inhibitory antibody#Adrecizumab”@ESICM#lives2019. This drug candidate developed by@Adrenomed has a novel MoA to restore#vascularintegrity https://bit.ly/2kH2dEY pic.twitter.com/o2PMtuvYZ7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Adrenomed announces the successful completion of enrollment in the 300-patient PoC Phase II trial, AdrenOSS-2. “By restoring#vascularintegrity, we aim to provide#ICU physicians with a new therapy for#sepsis patients,” said Dr. Andreas Bergmann, CSO https://bit.ly/2lJiKcd pic.twitter.com/PoB86Q66Oc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Frauke Hein, CBO of
#Adrenomed, will give a “Spotlight Talk on Sepsis” today at the#EBDC2019 in#Heidelberg. Discover the latest knowledge on#sepsis and@adrenomed’s role in tackling this awful disease by restoring#vascularintegrity https://bit.ly/2lLKV9S pic.twitter.com/N1iFnvSWdN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

Who are you most excited to meet! 
